---
title: "002864.SZ (002864.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002864.SZ/news.md"
symbol: "002864.SZ"
name: "002864.SZ"
parent: "https://longbridge.com/en/quote/002864.SZ.md"
datetime: "2026-05-20T12:04:23.545Z"
locales:
  - [en](https://longbridge.com/en/quote/002864.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002864.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002864.SZ/news.md)
---

# 002864.SZ (002864.SZ) — Related News

### [Panlong Pharmaceutical achieves record revenue: Innovation-driven momentum, high dividends show sincerity](https://longbridge.com/en/news/284487908.md)
*2026-04-29T03:34:11.000Z*
> In the fiscal year 2025, Panlong Pharmaceutical achieved a total operating revenue of 1.141 billion yuan, a year-on-year

### [Panlong Pharmaceutical: Net profit of 96.2794 million yuan in 2025, a year-on-year decrease of 19.95%](https://longbridge.com/en/news/284181445.md)
*2026-04-27T09:00:11.000Z*
> Panlong Pharmaceutical announced that the operating revenue in 2025 is expected to be 1.141 billion yuan, a year-on-year

### [Panlong Pharmaceutical: Director Zhu Wenfeng reduced his holdings by 0.0212% of shares](https://longbridge.com/en/news/279030065.md)
*2026-03-13T10:53:07.000Z*
> Panlong Pharmaceutical announced that director Zhu Wenfeng reduced his holdings of the company's shares by 22,500 shares

### [Panlong Pharmaceutical obtained the drug registration certificate for Glucosamine Sulfate Capsules](https://longbridge.com/en/news/277602741.md)
*2026-03-03T10:21:02.000Z*
> According to the Zhitong Finance APP, Panlong Pharmaceutical announced that the company has received the "Drug Registrat

### [Panlong Pharmaceutical: Ketoprofen Gel Patch has received the Drug Clinical Trial Approval Notice](https://longbridge.com/en/news/275585530.md)
*2026-02-11T09:51:43.000Z*
> Panlong Pharmaceutical announced that the company has received the "Drug Clinical Trial Approval Notification" issued by

### [The A-shares opened lower and rose higher, with all three major indices turning positive. The chemical and electric grid sectors collectively surged, the Hang Seng Index fell over 1%, tech stocks continued to decline, and Shanghai silver dropped over 13%](https://longbridge.com/en/news/275063436.md)
*2026-02-06T08:24:36.000Z*
> Chinese medicine stocks opened sharply higher, with Panlong Pharmaceutical and TY PHAR. hitting the daily limit, and Bio

### [A-shares open: Shanghai Composite Index down 0.87%, ChiNext Index down 1.15%, traditional Chinese medicine sector and tax rebate concept stocks rise, while gold, non-ferrous metals, and oil and gas sectors continue to adjust](https://longbridge.com/en/news/275057205.md)
*2026-02-06T01:37:17.000Z*
> The three major A-share indices opened lower, with the Shanghai Composite Index down 0.87% and the ChiNext Index down 1.

### [](https://longbridge.com/en/news/275055771.md)
*2026-02-06T01:27:03.000Z*
> Chinese medicine stocks opened sharply higher, with Panlong Pharmaceutical and TY PHAR. hitting the daily limit, and Bio

### [Eight departments issued a heavy document! The Chinese medicine sector exploded, Zhendong Pharmacy surged over 19%, TY PHAR. and Hansen Pharmaceutical hit the daily limit](https://longbridge.com/en/news/275061561.md)
*2026-02-06T02:27:17.000Z*
> The Chinese medicine sector surged against the trend in the morning session, with Zhendong Pharmacy rising over 19%, and